Størstedelen af de almindelige bivirkninger var dog milde til moderate, de startede som regel tidligt i behandlingen, og forsvandt for det meste ved fortsat behandling.
However, the majority of common adverse reactions were mild to moderate, they usually start early in therapy, and most tended to disappear even as therapy was continued.